Welcome to episode 141 of the AI in Action podcast, the show where we break down the hype and explore the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives.

Powered by Alldus International, our goal is to share with you the insights of technologists and data science enthusiasts to showcase the excellent work that is being done within AI in the United States and Europe.

Today’s guest is Serghei Glinca, co-founder & CEO at CrystalsFirst. CrystalsFirst unifies biotech and tech to significantly accelerate drug design for challenging targets. CrystalsFirst’s unlocks the access to chemical matter using the combination of its proprietary SmartSoak-based high-performance soaking systems and scaling computational methods. Since launching the company in 2018, CrystalsFirst has closed deals and produced successful results with big pharma and ambitious biotech companies.

In the show, Serghei will tell you about:

The problem they are solving within Drug Discovery 

Their work within Structured Biology 

How they combine technology and data to impact healthcare 

Obstacles they need to overcome 

How AI and Data will continue to shape the industry 

To find out more about Serghei and his work at CrystalsFirst, check out the website www.crystalsfirst.com or follow them on Linkedin. You can also connect with Serghei on Linkedin and follow him on Twitter @serghei_g. 

What did you make of Serghei’s podcast? Where do you see the future of Artificial Intelligence within Healthcare heading in the next few years? We would love to hear your thoughts on this episode, so please leave a comment below.

If you would like to hear more from AI in Action then please subscribe and don’t forget to like and share with your friends on social media.

Subscribe to The Alldus Podcast: